VRF <- PVRF * PVR * BW #interstitial fluid volume of the rest of body kg=L
VRT <- VR - VRF #tissue volume of the rest of body kg=L
#Capillary surface area for each tissue (Ai) as percentage of body weight
#or weight of corresponding tissue (PAi, m^2/g) and surface area (m^2)
PAK <- 350e-4 #[cm2/g]*1e-4--> m^2/g  https://doi.org/10.1111/j.1748-1716.1963.tb02652.x
AK <- PAK * VK * 1e3 #kidney surface area (m^2)
PAKG <- 68.90e-4
AKG <- PAKG * VK * 1e3 #the surface area of glomerular capillary (m^2)
PAL <- 250e-4
AL <- PAL * VL * 1e3 #liver surface area (m^2)
PAST <- 100e-4 #Cheng et al., 2017 value for gut
AST <- PAST * VST * 1e3 #stomach surface area (m^2)
PASTL<- 100e-4 #Cheng et al., 2017 value for gut
ASTL<- PASTL * VSTL #stomach lumen surface area (m^2)
PAIN <- 100e-4 #Cheng et al., 2017 value for gut
AIN <- PAIN * VIN * 1e3 #intestine surface area (m^2)
#Calculations of rat intestinal lumen surface area based on Kothari et al. (2020),https://doi.org/10.1002/btm2.10146
# Lengths
L_duodenum <- 9.6# cm
L_jejunum <- 26 #cm
L_ileum <- 34.4# cm
# Inner diameters
d_duodenum <- 2.21 #cm
d_jejunum <- 2.56 #cm
d_ileum <- 3.36 #cm
SA <- 2*pi*(d_duodenum/2)*L_duodenum + 2*pi*(d_jejunum/2)*L_jejunum + 2*pi*(d_ileum/2)*L_ileum #cm^2
n <- 5 #enlargement factor of apical membrane of proximal tubule or enterocytes
AINL <- n * SA * 1e-4 #m^2
PAM <- 70*1e-4 #m2/g tissue
AM <- PAM * VM *1e03 #muscle surface area (m^2)
PAA <- 70e-4 #m2/g tissue
AA <- PAA * VA *1e03#adipose surface area (m^2)
PAR <- 100e-4#m2/g tissue
AR <- PAR * VR *1e03#surface area of rest of body (m^2)
PLu <- 250e-4  #m2/g tissue      #https://doi.org/10.1111/j.1748-1716.1963.tb02652.x
ALu <- PLu* VLu*1e03 #lung surface area (m^2)
PSP <- 70e-4 #m2/g tissue
ASP <- PSP* VSP *1e03 #spleen surface area (m^2), same as muscle #assumption
#PH <- 50.3e-3/302 #50313 mm^2/kg --> *e-6 --> m^2/kg  https://doi.org/10.1007/BF00410278
PH <-  67.8# mm^2/mm^3 <--> m2/L of tissue, from group III in https://doi.org/10.1016/S0022-2828(87)80533-3
AH <- PH* VH #heart surface area (m^2)
PBr <- 240e-4#m2/g tissue     #https://doi.org/10.1111/j.1748-1716.1963.tb02652.x
ABr <- PBr* VBr *1e03 #brain surface area (m^2)
PT <- 70e-4#m2/g tissue
AT <- PT* VT *1e03 #gonads surface area (m^2), same as muscle #assumption
PSK <- 70e-4#m2/g tissue
#ASK <- PSK* VSK * 1e7 #skin surface area (m^2), same as muscle #assumption
ASK <- PSK* VSK*1e03 #skin surface area (m^2), same as muscle #assumption
###############################
#-----------------------------#
#   Reflection Coefficients   #
#-----------------------------#
###############################
# Pore diameters from Price & Gesquiere (2020)
DpKi <- 200 #nm
DpLi <- 280 #nm
DpSt <- 80 #nm, assumption
DpIn <- 80 #nm
DpMu <- 80 #nm
DpAd <- 80 #nm, assumption
DpRe <- 80 #nm, assumption
DpLu <- 27 #nm
DpSp <- 5000 #nm
DpHt <- 50 #nm
DpBr <- 0.99 #nm
DpGo <- 80 #nm, assumption
DpSk <- 60 #nm
Dps <- c(DpKi, DpLi, DpSt, DpIn, DpMu, DpAd, DpRe, DpLu, DpSp, DpHt, DpBr, DpGo, DpSk)
s_r <- rep(NA, length(Dps))
# (C-C) bond length is 0.154 nm ==> 7*0.154 = 1.078nm
# For carboxyl group we assume 0.13nm, So the total size is around 1.2 nm
np_size <- 1.2/2 #nm, PFOA equivalent radius
for (i in 1:length(s_r)){
a_r <- np_size/(Dps[i]/2)
Phi = (1-a_r)^2
F_r <- (((1-a_r^2)^(3/2))*Phi)/(1+0.2*(a_r^2)*(1-a_r^2)^16)
G_r <- ((1- (2*a_r^2)/3 - 0.20217*a_r^5 )/ (1-0.75851*a_r^5)) - (0.0431*(1-(1-a_r^10)))
s_r[i] <- 1-(1-(1-Phi)^2)*G_r+2*a_r^2*Phi*F_r
}
SKi <- s_r[1]
SLi <- s_r[2]
SSt <- s_r[3]
SIn <- s_r[4]
SMu <- s_r[5]
SAd <- s_r[6]
SRe <- s_r[7]
SLu <- s_r[8]
SSp <- s_r[9]
SHt <- s_r[10]
SBr <- 1
SGo <- s_r[12]
SSk <- s_r[13]
#Effective permeability (Peff, in m/h) for blood (B), liver(L), kidney(K),
#stomach(ST),intestine (IN), adipose(A), muscle(M), spleen (SP), heart (H),
#brain (Br), gonads (T), rest of body(R)
#PeffB <- 4.98e-8*3600*CF_Peff1
PeffK <-5e-8*3600*CF_Peff
PeffL <- 5e-8*3600*CF_Peff
PeffST <- 5e-8*3600*CF_Peff #assumption
PeffIN <- 5e-8*3600*CF_Peff#assumption
PeffA <-5e-8*3600*CF_Peff
PeffM <- 5e-8*3600*CF_Peff
PeffR <- 5e-8*3600*CF_Peff
PeffLu <- 5e-8*3600*CF_Peff #assumption
PeffSP <- 5e-8*3600*CF_Peff #assumption
PeffH <- 5e-8*3600*CF_Peff #assumption
PeffBr <- 5e-8*3600*CF_Peff #assumption
PeffT <- 5e-8*3600*CF_Peff #assumption
PeffSK <- 5e-8*3600*CF_Peff #assumption
####################################
#----------------------------------#
#             Flow Rates           #
#----------------------------------#
####################################
####################################
#            Blood flow rates      #
####################################
#(QBi, in L/h) to different tissues (i=L, K, G, A, M, R)
#as a percentage of cardiac output (Qcardiac L/h), which itself is a function
#of body weight (BW)
Qcardiac <- 0.235 * (BW^0.75) *60 #L/min->*60-> L/h
PQBK <- 14.1/100 #Brown et al. 1997, p 438, Table 23
QBK <- PQBK * Qcardiac #L/h
PQBL <- 2.1/100
QBL <- PQBL * Qcardiac #L/h Brown et al. 1997, p 438, Table 23
PQBST <- 0.16/100 #https://doi.org/10.3390/pharmaceutics6010097 Qcard=0.235*(0.250^0.75)*60 (L/h) and PQBST = (8/1000)/Qcard *100
QBST <- PQBST * Qcardiac #L/h
PQBIN <- 9/100 #https://doi.org/10.3390/pharmaceutics6010097 Qcard=0.235*(0.250^0.75)*60 (L/h) and PQBIN = (451/1000)/Qcard *100
QBIN <- PQBIN * Qcardiac #L/h
PQBM <- 27.8/100 #Brown et al. 1997, p 438, Table 23
QBM <- PQBM * Qcardiac #L/h
PQBA <- 7/100 #Brown et al. 1997, p 438, Table 23
QBA <- PQBA * Qcardiac #L/h
PQBLu <- 1
QBLu <- PQBLu * Qcardiac #L/h
PQBSP <- 0.75/100 #https://doi.org/10.3390/pharmaceutics6010097 Qcard=0.235*(0.250^0.75)*60 (L/h) and PQBSP = (37.5/1000)/Qcard *100
QBSP <- PQBSP * Qcardiac #L/h
PQBH <- 5.1/100 #Brown et al. 1997, p 438, Table 23
QBH <- PQBH * Qcardiac #L/h
PQBBr <- 2.0/100 #Brown et al. 1997, p 438, Table 23
QBBr <- PQBBr * Qcardiac #L/h
PQBT <- 0.28/100 #https://doi.org/10.1152/ajpregu.1987.253.2.R228 Qcard=0.235*(0.335^0.75)*60 (L/h) and PQBT = (0.295*60/1000)/Qcard *100
QBGo <- PQBT * Qcardiac #L/h
PQBSK <- 1.35/100 #https://doi.org/10.1111/1523-1747.ep12277181 Qcard=0.235*(0.2^0.75)*60 (L/h) and PQBSK = (0.95*60/1000)/Qcard *100
QBSK <- PQBSK * Qcardiac #L/h
# Total blood outflow from liver
QBLtot <- QBL+QBSP+QBIN+QBST
PQBR = 1 - PQBK - PQBST - PQBIN - PQBL - PQBM - PQBA - PQBH - PQBSK - PQBSP - PQBT - PQBBr
QBR <- PQBR * Qcardiac #L/h
#############################################
#               Lymph flow rates            #
#############################################
#Paracellular flow as a fraction of organ blood flow,
#from Niederalt et al.(2017). https://doi.org/10.1007/s10928-017-9559-4
fQparaKi <- 7.09E-4
fQparaLi <- 1.99E-2
fQparaSt <- 2.04E-3
fQparaIn <- (1.95E-3+1.44E-2)/2
fQparaMu <- 2.01E-3
fQparaAd <- 2.0E-3 # Assumption based on 1/500 of flow (Dosgra et al. 2020, https://doi.org/10.1016/j.csbj.2020.02.014)
fQparaRe <- 2.0E-3 # Assumption based on 1/500 of flow (Dosgra et al. 2020, https://doi.org/10.1016/j.csbj.2020.02.014)
fQparaLu <- 3.56E-5
fQparaSp <- 1.99E-2
fQparaHt <- 1.47E-3
fQparaBr <- 7.27E-5
fQparaGo <- 1.11E-2
fQparaSk <- 3.52E-3
#Estimation of lymph flow rates:
QparaKi <- fQparaKi*QBK
QparaLi <- fQparaLi*QBL
QparaSt <- fQparaSt*QBST
QparaIn <- fQparaIn*QBIN
QparaMu <- fQparaMu*QBM
QparaAd <- fQparaAd*QBA
QparaRe <- fQparaRe*QBR
QparaLu <- fQparaLu*QBLu
QparaSp <- fQparaSp*QBSP
QparaHt <- fQparaHt*QBH
QparaBr <- fQparaBr*QBBr
QparaGo <- fQparaGo*QBGo
QparaSk <- fQparaSk*QBSK
##################################
#     Other fluids flow rates    #
##################################
#Flow rate of fluids including feces, bile, urine and glomerular filtration rate (GFR), in L/h
#Qfeces <- 5.63/1000/24 #mL water/d --> L/h
PQbile <- 90/1000/24 # [mL/d/kg BW]/1000/24 --> L/h/kg BW
Qbile <- PQbile * BW #L/h
#PQurine <- 200/1000/24 #mL/d/kg BW --> L/h/kg
#Qurine <- PQurine * BW #L/h
Qfeces <- (8.18/0.21)*BW #g/kg BW, based on Cui et al.(2010)
feces_density <- 1.29 #g/cm^3 --> g/mL from Lupton 1986, Fig 1. Fiber free control diet, https://doi.org/10.1093/jn/116.1.164
if (sex == "M"){
PQGFR <- 62.1  #L/h/kg   Corley et al., 2005 https://doi.org/10.1093/toxsci/kfi119, GFRC --> scaled fraction of kidney weight
QGFR <- PQGFR * VK #L/h
Qurine <- (60/1000)*BW/24 #([ml/d/kg]/1000)*BW/24 --> L/h, from Schmidt et al., 2001, 10.1002/nau.1006
}else if(sex == "F"){
PQGFR <- 41.04  #L/h/kg  Corley et al., 2005 https://doi.org/10.1093/toxsci/kfi119, GFRC --> scaled fraction of kidney weight
QGFR <- PQGFR * VK #L/h
Qurine <- (85/1000)*BW/24 #([ml/d/kg]/1000)*BW/24 --> L/h, from Schmidt et al., 2001, 10.1002/nau.1006
}
QGE<- 0.54/BW^0.25 #gastric emptying time (1/(h*BW^0.25)); from Yang, 2013
#QGE<- VSTL * 2.03 #L/h https://doi.org/10.1124/dmd.118.085902, Table 5
#Albumin concentration in blood and interstitial fluid compartments(mol/m^3 = 1e-6* nmol/g)
CalbB <- 486*1e-03 # #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbKF <- 243*1e-3 # #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbLF <- 243*1e-3 # #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbGF <- 146*1e-3 #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbSTF <- 146*1e-3 # [umol/L]*1e-3 -->(mol/m3), same as Gut (assumption)
CalbINF <- 146*1e-3 #[umol/L]*1e-3 -->(mol/m3), same as Gut (assumption)
CalbMF <- 146*1e-3 #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbAF <- 73*1e-3 #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbRF <- 73*1e-3 #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CalbLuF <- CalbGF #assumption
CalbLuAF <- 10/100 * CalbB #based on Woods et al. 2015 statement https://doi.org/10.1016/j.jconrel.2015.05.269
MW_albumin <- 66.5#kg/mol
CalbSPF <- 243e-3 #[umol/L]*1e-3 -->(mol/m3), same as liver (assumption)
CalbTF <- 41/MW_albumin #mg/mL-->  (mol/m3) from https://doi.org/10.1210/endo-116-5-1983 --> 41 mg/mL, MW=65 kg/mol
CalbHF <- 65/MW_albumin##mg/mL--> (mol/m3) https://doi.org/10.1007/s12291-010-0042-x --> 6.5 g/100 g tissue, MW=65 kg/mol
CalbBrF <- 8e-2/MW_albumin  ##mg/mL--> (mol/m3) https://doi.org/10.1016/0014-4886(90)90158-O --> 0.08 g/L, MW=65 kg/mol
CalbSKF <- 21/MW_albumin ##mg/mL-->  (mol/m3) https://doi.org/10.1111/j.1748-1716.1973.tb05464.x -->Table 2: 2.1 g/100 mL
#Alpha2mu-globulin concentration in kidney tissue (mol/m3)
if (sex == "M"){
Ca2uKT <- 110e-3 #mol/m3
}else if(sex == "F"){
Ca2uKT <- 0 #mol/m3
}
#LFABP concentration in kidney and liver tissue (mol/m^3)
CLfabpKT <- 2.65*1e-3  #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
CLfabpLT <- 133*1e-3  #[umol/L]*1e-3 -->(mol/m3), from Cheng et al. (2017)
#======Table S2=======#
#Equilibrium association constant (m^3/mol= 10^-3*M-1) for albumin(Ka), LFABP(KL_fabp),
#and alpha2mu-globulin(Ka2u). See SI section S2-2 for details
#Ka <-  24.18 #3.1*7.8 m3/mol multiplying by number of binding sites (Cheng et al. 2021)
Ka <-  1e05*1e-3 #[L/mol]*1e-3--->m3/mol
KLfabp <- (1.2e5+4e4+1.9e4)*1e-3  #[L/mol]*1e-3--->m3/mol, value from Cheng et al. (2017)
Ka2u <- 5*1e02*1e-3 #[L/mol]*1e-3--->m3/mol, value from Cheng et al. (2017)
#Overall mass transfer coefficients between subcompartments and passive
#diffusion rate constants. See SI section S3-1 for details
#passive diffusion rates
ClLFT_unscaled= 67.8 #uL/min/10^6 cells, Han et al. 2008
ClKFT_unscaled= 17.5 #uL/min/mg protein, Yang et al. 2010
ClSTFT_unscaled= 18.1 #uL/min/mg protein, Kimura et al. 2017
ClINFT_unscaled= 18.1 #uL/min/mg protein, Kimura et al. 2017
ClMFT_unscaled= 18.1 #same as ClGFT
ClAFT_unscaled= 18.1 #same as ClGFT
ClRFT_unscaled= 18.1 #same as ClGFT
ClLuFT_unscaled= 18.1 #same as ClGFT
ClSPFT_unscaled= 18.1 #same as ClGFT
ClHFT_unscaled= 18.1 #same as ClGFT
ClBrFT_unscaled= 18.1 #same as ClGFT
ClTFT_unscaled= 18.1 #same as ClGFT
ClSKFT_unscaled= 18.1 #same as ClGFT
#For all CMTs
MW = 414.07 #g/mol, PFOA molecular weight
Acell = 4000 #um^2/cell
#Kidney
kidney_protein_per_rat <- 1000*(0.218+0.225+0.212)/3#mg of protein per rat  (Addis 1936)
rat_weight_addis <- 200 #g, average rat weight in Addis, 1936
rat_kidney_weight_addis <- rat_weight_addis*0.0073 # kidney fraction to BW, Brown (1997)
kidney_protein_per_gram <- kidney_protein_per_rat/rat_kidney_weight_addis #mg of protein/g kidney
kidney_cells = 1.47e07 #cells/g https://doi.org/10.1038/s41598-024-53270-2
kidney_cells_total <- kidney_cells* (1000*VKT)
kidney_protein_total <- kidney_protein_per_gram* (1000*VKT) #mg
ClKFT <- ClKFT_unscaled * kidney_protein_total #uL/min for the whole kidney
# Uptake for the whole kidney tissue
kKFKT <- (60*ClKFT)/1e06 #L/h
kFKT <- PeffK * AK * n
#Oatp kidney
VmK_Oatp_in_vitro <- 9.3 #nmol/mg protein/min (Weaver et al. 2010)
VmK_Oatp_scaled <- 60*VmK_Oatp_in_vitro*MW*kidney_protein_total/1000  #physiologically scaled to in vivo, ug/h
VmK_Oatp <- VmK_Oatp_scaled*RAFOatp_k #in vivo value, in  ug/h
KmK_Oatp=  126.4*MW# [umol/L] * g/mol  --> ug/L, from Weaver et al. (2010)
#oat1 kidney
VmK_Oat1_in_vitro= 2.6 #nmol/mg protein/min (Weaver et al. 2010)
VmK_Oat1_scaled = 60*VmK_Oat1_in_vitro*MW*kidney_protein_total/1000 #physiologically scaled to in vivo, ug/h
VmK_Oat1= VmK_Oat1_scaled*RAFOat1 #in vivo value, in   ug/h
KmK_Oat1= 43.2 * MW #umol/L (Weaver et al. 2010) --> ug/L
#oat3 kidney
VmK_Oat3_in_vitro= 3.8 #nmol/mg protein/min  (Weaver et al. 2010)
VmK_Oat3_scaled = 60*VmK_Oat3_in_vitro*MW*kidney_protein_total/1000 #physiologically scaled to in vivo, ug/h
VmK_Oat3 = VmK_Oat3_scaled*RAFOat3 #in vivo value, in   ug/h
KmK_Oat3= 65.7 * MW #umol/L (Weaver et al. 2010) --> ug/L
#Urat1 kidney
VmK_Urat_in_vitro= 1520e-3 #nmol/mg protein/min  (Lin et al. 2023)
VmK_Urat_scaled = 60*VmK_Urat_in_vitro*MW*kidney_protein_total/1000 #physiologically scaled to in vivo, ug/h
VmK_Urat = VmK_Urat_scaled*RAFUrat #in vivo value, in   ug/h
KmK_Urat = 820.04 * MW #umol/L (Lin et al. 2023) --> ug/L
#Liver
liver_protein_per_rat <- 1000*(1.52+1.53+1.52)/3#mg of protein per rat  (Addis 1936)
rat_weight_addis <- 200 #g, average rat weight in Addis, 1936
rat_liver_weight_addis <- rat_weight_addis*0.0366 # liver fraction to BW, Brown (1997)
liver_protein_per_gram <- liver_protein_per_rat/rat_liver_weight_addis #mg or protein/g liver
liver_cells = 117*10^6 #hepatocytes per g of liver (Sohlenius-Sternbeck et al. 2006) (2e09 cells: https://bionumbers.hms.harvard.edu/bionumber.aspx?s=n&v=4&id=110895)
ClLFT <- ClLFT_unscaled*(liver_cells/(10^6))*(VLT*1000) #uL/min for the whole liver
kLFLT <-  (60*ClLFT)/1e06 #L/h
#oatp1-liver
VmL_Oatp_in_vitro= 9.3 #nmol/mg protein/min  (Weaver et al. 2010)
VmL_Oatp_scaled = 60*VmL_Oatp_in_vitro*MW*liver_protein_per_gram*(VL*1000)/1000   #physiologically scaled to in vivo, ug/h
VmL_Oatp = VmL_Oatp_scaled*RAFOatp_l #in vivo value, in  ug/h
KmL_Oatp = KmK_Oatp #same as kidney
#oatp2b1-liver
VmL_Oatp2_in_vitro= 1493e-3 #nmol/mg protein/min  (Lin et al. 2023)
#physiologically scaled to in vivo
VmL_Oatp2_scaled = 60*VmL_Oatp2_in_vitro*MW*liver_protein_per_gram*(VL*1000)/1000  #ug/h
VmL_Oatp2 = VmL_Oatp2_scaled*RAFOatp2_l #in vivo value, in  ug/h
KmL_Oatp2 = 148.68*MW #umol/L (Lin et al. 2023) --> ug/L
#Ntcp liver
VmL_Ntcp_in_vitro= 3#nmol/mg protein/min   Ruggiero et al. 2021
#physiologically scaled to in vivo
VmL_Ntcp_scaled = 60*VmL_Ntcp_in_vitro*MW*liver_protein_per_gram*(VL*1000)/1000 # ug/h
VmL_Ntcp = VmL_Ntcp_scaled*RAFNtcp #in vivo value, in  ug/h
KmL_Ntcp= 20 * MW #umol/L, Ruggiero et al. 2021 --> ug/L
#Muscle
muscle_cells= NA
muscle_protein <- 158.45 #mg/g muscle (protein data from Cheek et al.,1971
#and muscle mass from Caster et al.,1956)
muscle_protein_tot <- muscle_protein * (VMT*1000)
ClMFT <- ClMFT_unscaled * muscle_protein_tot#uL/min for the whole muscle comp
kMFMT <-  (60*ClMFT)/1e06 #L/h
#Intestine
intestine_cells = 93.1 * 2.365e6 #https://doi.org/10.1152/ajpgi.00290.2013
#cells per crypt Figure 3B, number of crypts:
#Figure 1, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1271340/
#(mean value of rat 300 and 400 g)
intestine_protein <- muscle_protein#NA#5034
intestine_protein_total <- intestine_protein*(1000*VINT)
ClINFT <- ClINFT_unscaled *intestine_protein_total#uL/min for the whole gut compartment
kINFINT <-  (60*ClINFT)/1e06 #L/h
# Following the calculations of Lin et al. (2023)
Awell = 9 #cm^2 (for a 35 mm culture dish)
Swell = 1.12 #cm^2
well_protein = 0.346 #mg protein
P = (well_protein * Awell)/Swell #mg protein/well
Papp = (ClINFT_unscaled*60*1e-03*P)/(Awell *2) #cm/h
P_passive = ( (Papp/100) * AINL)*1000 #L/h
#oatp2b1-intestine
VmIn_Oatp2_in_vitro= 456.63e-3 #nmol/mg protein/min  (Kimura et al., 2017),
#assuming that the mediated transport is performed only by this transporter
VmIn_Oatp2_scaled = 60*VmIn_Oatp2_in_vitro*MW*intestine_protein_total/1000   #physiologically scaled to in vivo, ug/h
VmIn_Oatp2 = VmIn_Oatp2_scaled*RAFOatp2_Int #in vivo value, in  ug/h, same RAF as in liver
KmIn_Oatp2 = 8.3*MW #umol/L (Kimura et al., 2017) --> ug/L
#Stomach
stomach_cells = NA
stomach_protein <- muscle_protein#NA#5034
stomach_protein_total <- stomach_protein*(1000*VSTT)
ClSTFT <- ClSTFT_unscaled *stomach_protein_total #uL/min for the whole gut compartment
kSTFSTT <-  (60*ClSTFT)/1e06 #L/h
# For identifiability reasons we assume that absorption is realised only through the intestines
kabST <- (kabs_st* ASTL)*1000 #L/h
#Adipose
adipose_cells = NA
adipose_protein <- muscle_protein#NA#5034
adipose_protein_total <- adipose_protein * (1000*VAT)
ClAFT <- ClAFT_unscaled * adipose_protein_total#uL/min
kAFAT <-  (60*ClAFT)/1e06 #L/h
#Rest of body
RoB_cells = NA
RoB_protein <- muscle_protein#18456
RoB_protein_total <- RoB_protein * (1000* VRT)
ClRFT <- ClRFT_unscaled * RoB_protein_total#uL/min
kRFRT <-  (60*ClRFT)/1e06 #L/h
#Lung
Lung_protein <- muscle_protein#18456
Lung_protein_total <- Lung_protein * (1000* VRT)
ClLuFT <- ClLuFT_unscaled * Lung_protein_total#uL/min
kLuTLuF <-  (60*ClLuFT)/1e06 #L/h
#Spleen
spleen_cells = 1.76e8 #cells/g tissue https://doi.org/10.1371/journal.pone.0059602 --> Figure 5C
spleen_protein <- muscle_protein#NA#5034
spleen_protein_total <- spleen_protein * (1000*VSPT)
ClSPFT <- ClSPFT_unscaled * spleen_protein_total#uL/min
kSPFSPT <-  (60*ClSPFT)/1e06 #L/h
#Heart
heart_cells = 3.3e8 #cells/g tissue  https://doi.org/10.1620/tjem.95.177
heart_protein <- muscle_protein#NA#5034
heart_protein_total <- heart_protein * (1000*VHT)
ClHFT <- ClHFT_unscaled * heart_protein_total#uL/min
kHFHT <-  (60*ClHFT)/1e06 #L/h
#Brain
brain_cells = 3.3e8/1.8 #cells/g tissue https://doi.org/10.1523/JNEUROSCI.4526-04.2005 --> Table 1
brain_protein <- muscle_protein#NA#5034
brain_protein_total <- brain_protein * (1000*VBrT)
ClBrFT <- ClBrFT_unscaled * brain_protein_total#uL/min
kBrFBrT <-  (60*ClBrFT)/1e06 #L/h
#gonads
gonads_cells = 1.85e7+1.58e7 #Sertoli and Leydig cells/g tissue  https://doi.org/10.1007/BF00297504 --> Figure 2, LC and SC cells
gonads_protein <- muscle_protein#NA#5034
gonads_protein_total <- gonads_protein * (1000*VTT)
ClTFT <- ClTFT_unscaled * gonads_protein_total#uL/min
kTFTT <-  (60*ClTFT)/1e06 #L/h
#Skin
skin_cells = NA
skin_protein <- muscle_protein#NA#5034
skin_protein_total <- skin_protein * (1000*VSKT)
ClSKFT <- ClSKFT_unscaled * skin_protein_total#uL/min
kSKFSKT <-  (60*ClSKFT)/1e06 #L/h
return(list('VB'=VB, 'Vplasma'=Vplasma, 'VK'=VK, 'VKB'=VKB,
'VKF'=VKF, 'VKT'=VKT, 'VFil'=VFil,
'VL'=VL, 'VLB'=VLB, 'VLF'=VLF, 'VLT'=VLT,
'VM'=VM, 'VMB'=VMB, 'VMF'=VMF, 'VMT'=VMT, 'VA'=VA, 'VAB'=VAB,
'VAF'=VAF, 'VAT'=VAT, 'VR'=VR, 'VRB'=VRB,
'VRF'=VRF, 'VRT'=VRT, 'Vven' = Vven,
'Vart' = Vart, 'VLu'=VLu, 'VLuB'=VLuB, 'VLuF'=VLuF,
'VLuAF'=VLuAF, 'VLuT'=VLuT,
'VSP'=VSP, 'VSPB'=VSPB, 'VSPF'=VSPF, 'VSPT'=VSPT,
'VH'=VH, 'VHB'=VHB, 'VHF'=VHF, 'VHT'=VHT,
'VBr'=VBr, 'VBrB'=VBrB, 'VBrF'=VBrF, 'VBrT'=VBrT,
'VT'=VT, 'VTB'=VTB, 'VTF'=VTF, 'VTT'=VTT,
'VIN'=VIN, 'VINB'=VINB, 'VINF'=VINF, 'VINT'=VINT,
'VST'=VST, 'VSTB'=VSTB, 'VSTF'=VSTF, 'VSTT'=VSTT,
'VSTL'=VSTL, 'VINL'=VINL,
'VSK'=VSK,'VSKB'=VSKB, 'VSKF'=VSKF, 'VSKT'=VSKT,
'AK'=AK, 'AKG'=AKG, 'AL'=AL,
'AM'=AM, 'AA'=AA, 'AR'=AR, 'ALu'= ALu,
'ASP'=ASP, 'AH'=AH, 'ABr'=ABr, 'AST'= AST,
'AIN'=AIN, 'AT'=AT,
'ASK'= ASK,
"SKi" = SKi,"SLi" = SLi,"SSt" = SSt,"SIn" = SIn,
"SMu" = SMu,"SAd" = SAd,"SRe" = SRe,"SLu" = SLu,
"SSp" = SSp,"SHt" = SHt,"SBr" = SBr,"SGo" = SGo,
"SSk" = SSk,
#'PeffB'=PeffB,
'PeffK'=PeffK, 'PeffL'=PeffL,
'PeffA'=PeffA, 'PeffM'=PeffM, 'PeffR'=PeffR, 'PeffLu' = PeffLu,
'PeffSP'=PeffSP, 'PeffH'=PeffH, 'PeffBr'=PeffBr, 'PeffST' = PeffST,
'PeffIN'=PeffIN, 'PeffT'=PeffT,
'PeffSK' = PeffSK,    "P_liver_bile" = P_liver_bile,
'Qcardiac'=Qcardiac, 'QBK'=QBK,
'QBL'=QBL, 'QBLtot'=QBLtot,
'QBM'=QBM, 'QBA'=QBA,
'QBR'=QBR, 'QBLu'=QBLu, 'Qfeces'=Qfeces, 'feces_density'=feces_density,
'Qbile'=Qbile, 'QGFR'=QGFR,'Qurine'=Qurine,
'QBSP'=QBSP, 'QBH'=QBH, 'QBBr'=QBBr, 'QBST'=QBST,
'QBIN'=QBIN, 'QGE'=QGE,
'QBGo'=QBGo,
'QBSK'=QBSK,
"QparaKi" = QparaKi,"QparaLi" = QparaLi,"QparaSt" = QparaSt,"QparaIn" = QparaIn,
"QparaMu" = QparaMu,"QparaAd" = QparaAd,"QparaRe" = QparaRe,"QparaLu" = QparaLu,
"QparaSp" = QparaSp,"QparaHt" = QparaHt,"QparaBr" = QparaBr,"QparaGo" = QparaGo,
"QparaSk" = QparaSk,
'CalbB'= CalbB, 'CalbKF'=CalbKF, 'CalbLF'=CalbLF,
'CalbMF'=CalbMF, 'CalbAF'=CalbAF, 'CalbRF'=CalbRF,
'CalbLuF' =CalbLuF, 'CalbSPF' =CalbSPF, 'CalbTF' =CalbTF, 'CalbHF' =CalbHF,
'CalbBrF' =CalbBrF, 'CalbSTF' =CalbSTF, 'CalbINF' =CalbINF,
'CalbSKF' =CalbSKF,
'Ca2uKT'=Ca2uKT,'CLfabpKT'=CLfabpKT,'CLfabpLT'=CLfabpLT,
'Ka'=Ka, 'Ka2u'=Ka2u, 'KLfabp'=KLfabp,
'ClLFT'=ClLFT, 'ClKFT'=ClKFT,
'ClMFT'=ClMFT,
'ClAFT'=ClAFT, 'ClRFT'=ClRFT, 'ClLuFT'=ClLuFT, 'ClSTFT'=ClSTFT,
'ClINFT'=ClINFT, 'ClSPFT'=ClSPFT, 'ClHFT'=ClHFT, 'ClBrFT'=ClBrFT,
'ClTFT'=ClTFT,
'ClSKFT'=ClSKFT,
'VmL_Oatp'=VmL_Oatp, 'KmL_Oatp'= KmL_Oatp, 'VmL_Ntcp'= VmL_Ntcp,
'VmL_Oatp2'=VmL_Oatp2, 'KmL_Oatp2'= KmL_Oatp2,
'VmIn_Oatp2'=VmIn_Oatp2, 'KmIn_Oatp2'= KmIn_Oatp2,
'KmL_Ntcp'= KmL_Ntcp,'VmK_Oatp'= VmK_Oatp,
'KmK_Oatp'=KmK_Oatp,
#'VmK_Osta'=VmK_Osta,'KmK_Osta'=KmK_Osta,
'VmK_Oat1'=VmK_Oat1, 'KmK_Oat1'=KmK_Oat1, 'KmK_Oat1'=KmK_Oat1,
'VmK_Oat3'=VmK_Oat3, 'KmK_Oat3'=KmK_Oat3,
'VmK_Urat'=VmK_Urat, 'KmK_Urat'=KmK_Urat,
'KmK_baso' = KmK_baso,
'VmK_baso' = VmK_baso,
'P_passive' = P_passive,
'kKFKT'=kKFKT, 'kFKT'=kFKT,
'kLFLT'=kLFLT, 'kAFAT'=kAFAT,
'kRFRT'=kRFRT,
'kabST'=kabST,
'kMFMT'=kMFMT, 'kLuTLuF' =kLuTLuF, 'kSPFSPT' =kSPFSPT,
'kSTFSTT' =kSTFSTT, 'kINFINT' =kINFINT, 'kHFHT' =kHFHT,
'kBrFBrT' =kBrFBrT, 'kTFTT' =kTFTT,
'kSKFSKT' =kSKFSKT,
"admin.time" = admin.time, "admin.dose" = admin.dose,
"admin.type" = admin.type, "MW"=MW
))
})
}
ABr
load("~/GitHub/PFAS_PBK_models/PFOA inhalation Rat/Scenarios/Scenario_1/Training/AAFE/.RData")
optimizer
load("~/GitHub/PFAS_PBK_models/PFOA inhalation Rat/Validation/Results of Scenarios Validation/Scenario_2 - different inits/Scenario_2_Differenet inits.RData")
optimizer
load("~/GitHub/PFAS_PBK_models/PFOA inhalation Rat/Scenarios/Scenario_2 - 1000 iterations/Training/AAFE/.RData")
optimizer
#path <- "C:/Users/ptsir/Documents/GitHub/PFAS_PBK_models/PFOA inhalation Rat/Validation/Training data"
path <- "C:/Users/dpjio/Documents/GitHub/PFAS_PBK_models/PFOA inhalation Rat/Validation/Results of Scenarios Validation/Scenario_2 - 1000 iterations"
setwd(path)
load("Scenario_2 - 1000 iterations.RData")
source("Validate_Cui2008.R")
rm(list = setdiff(ls(), c("path", "AAFE_Cui")))
setwd(path)
source("XY_Plot_tissues.R")
setwd(path)
load("Scenario_2 - 1000 iterations.RData")
source("Validate_Kemper2003_serum.R")
rm(list = setdiff(ls(),  c("path", "AAFE_Cui", "AAFE_Kemper_serum")))
setwd(path)
source("XY_Plot_serum.R")
setwd(path)
load("Scenario_2 - 1000 iterations.RData")
source("Validate_Kemper2003_excreta_Worley.R")
source("Validate_Kemper2003_excreta_Loccisano.R")
rm(list = setdiff(ls(),  c("path", "AAFE_Cui", "AAFE_Kemper_serum",
"AAFE_Worley", "AAFE_Loccisano")))
setwd(path)
source("XY_Plot_excreta.R")
setwd <- "C:/Users/dpjio/Documents/GitHub/PFAS_PBK_models/PFOA inhalation Rat/Validation/Results of Scenarios Validation/Scenario_2 - 1000 iterations"
df_AAFE <- data.frame("AAFE" = c(AAFE_Cui, AAFE_Kemper_serum, AAFE_Worley, AAFE_Loccisano ))
rownames(df_AAFE) <- c("tissues", "serum", "excreta_worley", "excreta_loccisano")
write.csv(df_AAFE,"AAFE_validation.csv")
